指南与共识放疗物理与技术姑息放疗与转移瘤

立体定向放疗治疗单元实施的实践调查与共识建议

Clinical practice in stereotactic radiotherapy delivery at treatment unit: a practitioner survey and consensus-based recommendations for multidisciplinary professional development.
指南 / 共识 · Radiat Oncol · 2025-03-13

该研究通过在线调查法国35家及国外14国15家放疗中心,了解立体定向放疗在治疗单元的实施方式与医生验证现状。调查显示法国62.9%的中心每次分次均由放疗医生验证,而国外35.3%仅验证首次分次。共识建议向首次由放疗医生验证、后续由放疗技师验证并保留医生按需介入的模式演进。

要点

  • 法国62.9%中心每次立体定向放疗分次均由放疗医生验证,国外35.3%仅验证首次分次。
  • 80%受访者认为放疗医生验证患者体位耗时或打断任务,41.8%认为系统使用无附加价值。
  • 多数科室负责人希望首次由放疗医生验证、后续由放疗技师验证,困难时医生可介入。

核心结论

  • 比较法国与国际实践后,确认有必要制定并统一治疗单元患者体位验证的建议。
  • 将能力转移至放疗技师的法规变革是关键,但需根据各中心和每位放疗技师的经验,以明确标准和习得曲线进行评估后调整。

研究设计与样本

  • 对法国综合癌症中心和大学医院放疗科负责人以及国际中心进行在线封闭式实践调查。
  • 共35家法国中心和来自14个国外的15家中心回复问卷。
  • 召开视频会议根据结果提出法规修改建议,最终由指导委员会制定建议并由法国综合癌症中心和大学医院放疗科负责人批准。

主要发现

  • 最常见的立体定向设备为Varian Truebeam STX®(45%)和Cyberknife®(39.2%)。
  • 60.5%的科室开展立体定向放疗超过10年,10.1%的科室不足5年。
  • 法国62.9%的科室每次分次均由放疗医生验证,国外35.3%仅验证首次分次,23.5%仅在出现问题时验证。
  • 80%认为放疗医生验证患者体位耗时或打断任务,41.8%认为系统使用无附加价值,33.1%认为导致机器时间损失。

关键数值与推荐

  • 多数科室负责人希望首次分次由放疗医生系统验证,后续所有分次由放疗技师验证,困难时保留放疗医生介入的可能性。
  • 据此制定了任务委托程序以满足上述需求。

临床怎么用

  • 作者建议向首次分次由放疗医生验证、后续分次由放疗技师验证并保留放疗医生按需介入的模式演进。
  • 作者认为将能力转移至放疗技师的法规变革是关键,但需根据各中心和每位放疗技师的经验调整。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Stereotactic radiation therapy (SRT) is on the rise around the world. We aimed to provide recommendations to streamline and assess medical practices in SRT delivery at treatment unit, while complying with legal obligations concerning safety. MATERIALS AND METHODS: We conducted an online closed practice survey for heads of radiotherapy departments both nationally in comprehensive cancer centers and university hospitals throughout France, and internationally. The aim was to obtain a better understanding of how the delivery of SRT at treatment unit was managed across different centers according to experience, and to the machines and repositioning techniques used. Radiation oncologists (ROs) were also asked to assess the difficulties of technical implementation in the department, and whether residents were involved in the validation and delivery of SRT. Differences among countries regarding legislation governing the validation of SRT sessions at treatment unit were also collected. A videoconference was then held to draw up proposals for regulatory changes based on the results obtained. Finally, recommendations were drawn up by the steering committee and approved by heads of radiotherapy departments in comprehensive cancer centers and university hospitals throughout France. RESULTS: Thirty-five French centers and 15 centers from 14 foreign countries responded to the questionnaire. The most common stereotactic machines were Varian Truebeam STX® (45%) and Cyberknife® (39.2%). The departments had been performing SRT for more than 10 years in 60.5% of cases, and for less than 5 years in 10.1% of cases. A RO validated the SRT fractions at each session in 62.9% of French departments, while in countries outside France RO validation concerned the first fraction only for 35.3% or was performed only in the event of an issue for 23.5%. RO patient positioning validation of SRT fractions were considered as: time-consuming / task-interrupting (80%); having no added value with regards its systematic use (41.8%); and leading to a loss of machine time (33.1%). Most heads of departments would like to see an evolution towards systematic RO validation for the first session, then validation by a radiation therapist (RTT) for all subsequent sessions, leaving open the possibility of RO intervention when required in case of difficulty. We drew up a task delegation procedure to meet these requirements. CONCLUSION: Comparing the French practice to international ones confirmed the need to develop and harmonize recommendations in terms of patient positioning validation at treatment unit. Regulatory changes incorporating a competence transfer to RTTs, particularly after the empowerment process, is key. However, these changes need to be adapted to the experience of each Center and to that of each RTT, as assessed with clearly established criteria and learning curve.

来源:Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Martz N, Marchesi V, Rogé M, et al. Clinical practice in stereotactic radiotherapy delivery at treatment unit: a practitioner survey and consensus-based recommendations for multidisciplinary professional development. Radiat Oncol. 2025. PMID: 40082901. doi:10.1186/s13014-025-02615-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。